Trial Profile
A Multicenter, Prospective, Randomized, Controlled Study to Evaluate the Efficacy of Addition of Alogliptin to the Alpha-glucosidase Inhibitors on Glycemic Control in Patients with Type 2 Diabetes mellitus Showing Inadequate Response to Alpha-glucosidase Inhibitors.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Alpha-glucosidase inhibitors
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Nov 2015 New trial record